Specific Imaging of Immune Cell Dynamics Using
Novel Tracer Strategies (IMI2)

Lawrencium Legal is partner in the IMI2 Immune-Image project (start date 1st of October 2019). Lawrencium Legal s responsible for support to the project, technology transfer, advice on intellectual property  rights, drafting of legal templates, advice on legal aspects of biobanking and clinical trials, data management plan and privacy..

Among the partners of Immune-Image are Roche, Pfizer, Bayer, Takeda, Novartis, Dutch universities, Spanish universities, German universities, UK universities, Belgian Universities.